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Background: Anthelmintic resistance (AR) is an increasing problem for the ruminant livestock sector worldwide.
However, the extent of the problem is still relatively unknown, especially for parasitic nematodes of cattle. The
effect of ivermectin (IVM) (Ivomec inj.®, Merial) was investigated in Swedish isolates of gastrointestinal nematode
(GIN) populations showing signs of AR in the field to further characterise the AR status by a range of in vivo and
in vitro methods.
Methods: Three groups, each of 11 calves, were infected with an equal mixture of third stage larvae (L3) of
Cooperia oncophora and Ostertagia ostertagi. Group A was inoculated with an IVM-susceptible laboratory isolate and
groups B and C with isolates originating from ‘resistant’ cattle farms. Faecal egg counts (FEC) were monitored from
0 to 45 days post infection (d.p.i.), and L3 were harvested continuously for larval migration inhibition testing (LMIT)
and species-specific PCR (ITS2). At 31 d.p.i., one calf from each group was necropsied and adult worms were
recovered pre-treatment. At 35 d.p.i., calves from all groups were injected with IVM at the recommended dose
(0.2 mg/kg bodyweight). At 45 d.p.i., another two animals from each group were sacrificed and established
gastrointestinal worms were collected and counted.
Results: A few animals in all three groups were still excreting eggs (50-150 per g faeces) 10 days post IVM injection.
However, there was no significant difference in the FEC reductions in groups A (95%; 95% CI 81-99), B (98%; 92-100)
and C (99%; 97-100) between 35 and 44 d.p.i. Furthermore, LMIT showed no significant difference between the
three groups. Approximately 100 adult O. ostertagi were found in the abomasum of one calf (group B), whereas low
to moderate numbers (400-12 200) of C. oncophora remained in the small intestine of the calves in all three groups at
45 d.p.i. PCR on L3 harvested from faecal samples up to 10 days post treatment showed a ratio of 100% C. oncophora
in the calves inoculated with isolates A and B, whereas C also had 8% O. ostertagi.
Conclusions: Overall, this experiment showed that the animals were successfully treated according to the Faecal
egg count reduction test (FECRT) standard (≥ 95% reduction). However, several adult worms of the dose-limiting
species C. oncophora demonstrably survived the IVM treatment.
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Gastrointestinal nematode (GIN) infections in livestock
are common world-wide and assessments have repeatedly
shown that they can cause considerable live weight gain
losses during the first grazing season of calves in Sweden
[1-3]. It has also recently been demonstrated that there is
a negative interaction between exposure to GIN and indi-
vidual daily milk yields in Swedish dairy herds, even when
the overall exposure is relatively low [4]. In temperate re-
gions of the world such as Sweden, the most important
GINs include Cooperia oncophora and the more patho-
genic Ostertagia ostertagi, which are usually present as
mixed infections in pasture-based cattle production [5].
The use of modern broad spectrum anthelmintics since
their introduction in the 1960s has been a convenient and
often efficient method to control parasite infections in
grazing livestock. However, recent reports have shown that
extensive use of anthelmintics has led to a worldwide
spread of anthelmintic resistance (AR) in the cattle indus-
try [6,7]. In Europe, AR to macrocyclic lactones (ML), the
market-dominating anthelmintic family, has been reported
for cattle nematodes in both the UK [8-13] and Belgium
[14]. Widespread resistance was also reported in a multi-
national European survey including German, Belgian and
Swedish farms [15]. In a recently performed two-year
Swedish faecal egg count reduction test (FECRT) in cattle,
the results indicated that the efficacy of topical ML
under Swedish field conditions is insufficient, and that
C. oncophora is the predominant species surviving
deworming [16].
Detection of AR is usually based on the FECRT and
resistance in ruminant parasitic nematodes is declared
when the reduction after ML treatment is ≤95% and
with a lower confidence interval (CI) of <90% [17]. AR
in trichostrongyloid cattle nematodes detected by
FECRT has been reported against all major anthelmintic
classes, i.e. against ML and to a lesser extent also the
well-investigated benzimidazoles (BZ) [7]. Multiple or
cross resistance to both compounds has also been re-
ported in several cases world-wide (for a review, see
[7]). In addition to FECRT, a range of in vitro bioassays
have recently been developed and validated for detec-
tion of AR in cattle nematodes, such as the egg hatch
test (EHT), the larval development test (LDT), and the
larval migration inhibition test (LMIT) [18,19]. Further-
more, there have been attempts to develop molecular-
based tests to identify ML resistance, by investigating
nematode-specific P-glycoprotein (Pgp) gene expression
[20-23] and altered avr-14B gene transcription patterns
[24], although no standardised test for routine screening
of AR is available as yet.
The survey by Demeler et al. [15] on the efficacy of
ML (Ivomec inj.®) included five cattle herds in central
Sweden. The evaluation was made among first seasongrazing (FSG) cattle some weeks after turnout, and was
conducted using the FECRT. It showed unsatisfactory ef-
ficacy results, with only one farm achieving acceptable
reductions in egg output in 2006. In 2007, the reduction
was insufficient on all farms where animals were treated
with IVM. Isolates from two of these Swedish farms
were collected and maintained for further testing. The
aim of the present study was to investigate suspected re-
sistance in these O. ostertagi and C. oncophora isolates
after IVM treatment, by performing a controlled efficacy
test but also by using a range of available in vivo and
in vitro methods for further characterisation of the AR
and species composition status.
Methods
Worm material
Three different worm isolates with mixed O. ostertagi and
C. oncophora L3 were used in this study. Isolate A was
obtained from Tierärztliche Hochschule, Hannover (TiHo),
but was originally identified at the Central Veterinary
Laboratory in Weybridge, UK, in 1997. It is a well-
investigated laboratory strain that has been repeatedly
passaged in calves and with no history of being refrac-
tory to treatment with any anthelmintics. Isolates B and
C were obtained from two Swedish farms and showed
poor reductions to IVM according to FECRT, with 84%
(95% CI: 67-95) and 85% (62-99) reductions, respectively,
at day 7 [15]. The two Swedish isolates were obtained by
collection of faecal samples from FSG at the two farms,
mixing them with vermiculite and then incubating them
under moist conditions for 2 weeks at 25°C. L3 were har-
vested by the inverted cover glass technique, and larval
cultures were identified according to the morphological
key in Borgsteede and Hendriks [25]. After harvest, L3
were passaged once and propagated at SLU’s research
department Götala, in naïve dairy cattle that never had
access to pasture and were checked for egg shedding
prior to experimental infection.
Housing and animals
The infection trial was performed during seven weeks in
February to April 2009 at SLU’s research department
Kungsängen, with dairy cattle born and bred on the
farm. A total of 33 calves were randomly allocated based
on weight and sex to three groups, each with three male
calves and eight heifers of the Swedish Red and White
breed. All animals were between 3 and 7 months old,
weaned but with no experience of grazing, and were
checked for GIN egg shedding prior to experimental
infection. All calves were weighed prior to the start, then
at 21, 35, 51 days post infection (d.p.i.) and when eutha-
nized. Weight varied from 81 to 234 kg, with an average
weight at 127 kg at the start of the trial. The calves were
allocated to different indoor pens, with 8-9 animals in
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slowly moving rubber mat removing manure. No changes
were made to the diet when the calves were participating
in the experiment.
Experimental infection and anthelmintic treatments
On day 1, each calf was infected with ~40,000 L3 of
O. ostertagi (50%) and C. oncophora (50%) in a small
volume of water. Isolates A, B and C were administered
to calves in groups A, B and C, respectively. At 35 d.p.i.,
animals with patent infections were treated with IVM
(Ivomec® vet.) as subcutaneous (s.c.) injections. Dosage
was according to standard recommendations, 1 mL per
50 kg body weight or 0.2 mg IVM per kg. Animals were
treated and the trial was performed according to formal
institutional ethical approval (C276/8).
Sampling and laboratory procedures
Individual faecal samples were collected rectally on 23 oc-
casions between 0 and 45 d.p.i., with more frequent sam-
pling after the third week. A modified McMaster method
[26] was used to determine the number of O. ostertagi and
C. oncophora eggs in 3 g of faeces, giving a diagnostic
sensitivity of 50 eggs per gram faeces (epg). In addition,
the FLOTAC© method [27] with a sensitivity of 2 epg,
based on 10 g faeces and 90 mL saturated NaCl, was
used at 35 and 44 d.p.i. for comparison. The anthelmintic
efficacy of the drug was interpreted through the FECRT,
by comparing the results of two different formulae [28].
The first one was based on each group’s arithmetic mean
reduction: FECR3 = 100 × (1 − [T2/T1]), using arithmetic
means and with no control group [29], where T is treated
hosts and the faecal samples were taken pre-treatment or
at the moment of treatment (1) and X days post-treatment
(2). Individually based FECR formulae were also calculated
using before and after treatment individual evaluations in
treated hosts: iFECR3 = (1/n) ∑ (100 × (1 − [Ti2/Ti1])),
where Ti2 is post-treatment and Ti1 is pre-treatment epg
in host i from a total of n hosts. Each host served as its
own control. The FECR data were compared (repeated
measures MANOVA) using SAS JMP software (version
10.0.2) and the Minitab statistics programme (version 15)
and considered significantly different at p < 0.05.
L3 were also cultured by pooling and mixing 10-20 g
of each faecal sample with vermiculite and incubating
for 2 weeks at 26-27°C. The number of L3 was then
counted and identified according to the morphological
key in Borgsteede and Hendriks [25].
Total worm counts
At 31 d.p.i., four days before IVM treatment, one animal
per group (A, B and C) was euthanized intravenously
with pentobarbital (ex tempore 300 mg/mL, 60 mL/calf).
Another two animals per group were euthanized at 45 d.p.i.,10 days post IVM treatment. The abomasum and approxi-
mately 7 m of the proximal small intestine (duodenum,
jejunum) were separated, truncated, and their contents
emptied into individual beakers. The mucosal surfaces
were carefully washed with tap water, and the total volume
of each calf ’s bowel contents was adjusted to 4 L. For each
calf, four 20-mL subsamples were then collected under
constant stirring from every vessel with bowel or aboma-
sum contents giving a detection level of >200 worms in
the original sample [3]. The abomasal mucosa was scraped
off into a separate bucket and digested for 6 h at 40°C in a
solution with 17 mL HCl (37%) and 10 g pepsin in 1 L
H2O. The total volume was adjusted to 2 L after digestion
and subsampling as above, giving a diagnostic sensitivity
of >100 worms. Sub-samples were stored at -20°C, stained
with Lugols iodine and examined to count and differenti-
ate worms. Results were compared via one-way ANOVA
and boxplots of worm counts (Minitab® 15.1.30.0. soft-
ware) and considered significantly different at p < 0.05.
Larval migration inhibition test
Larvae from faecal cultures (21-32 d.p.i.) from each
group were obtained via the inverted cover glass tech-
nique to ensure that only viable L3 were used. Larval
suspension was adjusted to approximately 100 L3 per
20 μL. IVM (MW 871) was purchased from Sigma (I8898).
A stock dilution of IVM 10−2 M (8.71 mg/mL) was
made in dimethyl sulphoxide (DMSO, 100%) and a fur-
ther dilution into 10 different concentrations of IVM
ranging between 10−5 and 5 × 10−10 M.
The LMIT was carried out with sheathed larvae follow-
ing the method of Demeler et al. [19]. L3 were incubated
in the gradually increasing concentrations of IVM at 28°C
in a 24-well plate (incubation plate). After 24 h, the whole
contents of each well (liquid + L3) were transferred onto
sieves (mesh size 28 μm) suspended on rows 1 and 3 of a
24-well Bacto agar (1.5%) coated plate (migration plate),
and allowed to migrate for a further 24 h at 28°C. For
every incubation plate, two migration plates were used.
After 24 h, migrated L3 in the wells of rows 1 and 3 and
non-migrated L3, flushed into corresponding wells of rows
2 and 4, were counted under a stereo microscope. Each
isolate was tested over a range of 10 drug concentrations
in duplicate (two migration plates per isolate), and nega-
tive (water, no drug) and positive (stock solution) controls
were run in duplicate on each plate. The percentage of
non-migrated L3 in the total amount of L3 was calculated
for the controls and every IVM concentration tested. The
data were analysed according to Demeler et al. [19] using
a logistic regression model to determine LC50/LC99 with
GraphPad Prism® software (version 5.02). The EC50 values,
the 95% confidence intervals and R2 values were calcu-
lated, and the three groups compared accordingly. Differ-
ences were considered significant at p < 0.05.
Figure 1 Faecal egg count patterns. Mean faecal egg count
patterns over time (McMaster method), showing a significant
difference (p = 0.002) in egg shedding patterns between isolates
(groups) A, B and C from 1-45 d.p.i. However, there was no significant
difference (p = 0.34) when comparing the egg shedding levels of the
three groups before treatment, 1-35 d.p.i. Group A was infected with a
propagated IVM-susceptible laboratory isolate and groups B and C with
two different Swedish field isolates showing phenotypic clinical
IVM resistance in field trials. All calves were treated with injectable
IVM at 35 d.p.i.
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Genomic DNA from L3 of unknown species (C. oncophora
or O. ostertagi) was isolated from single L3 for traditional
PCR. This was carried out via a crude method using pro-
teinase K and 10 mM Tris pH 7.6 in the wells of PCR
plates, with minor modifications, according to Zarlenga
et al. [30]. In brief, the temperature and incubation time
were reduced to 52°C and 1 h, instead of 65°C and 3 h,
and 800 μg mL−1 proteinase K was used instead of
10 μg mL−1. For each plate, ~ 50 single individual L3
were tested to determine whether they belonged to C.
oncophora or O. ostertagi, using species-specific primers
targeting the ITS-2 ribosomal DNA gene, as described
by Schnieder et al. [31] and Höglund et al. [32]. The pri-
mer sequences used were Cooperia ITS2 Forward 5’
TAA TGG CAT TTG TCT ACA TCT 3’ , Cooperia ITS2
Reverse 5’ ATG ATA ACG AAT ACT ACT ATC T 3’ ,
Ostertagia ITS2 Forward 5’ GTC GAA TGG TAT TTA
TTA CT 3’ and Ostertagia ITS2 Reverse 5’ TTA GTT
TCT TTT CCT CCG CT 3’. The reaction mixtures con-
tained 25 μL volume with 2.5 μL 10 × Buffer (10 mM Tris-
HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl2 ), 0.5 μL Forward
primer (10 pmol), 0.5 μL Reverse primer (10 pmol), 0.5 μL
dNTP (0.2 mM), 0.1 μL Polymerase AmpliTaq (0.5 U),
19.9 μL H2O, and 1 μL genomic DNA. Samples were run
in an Applied Biosystems 2720 Thermal Cycler. Cycling
conditions were denaturation at 94°C for 2 min followed
by 30 cycles of 94°C for 30 s, 55°C for 30 s and 72°C for 1
minute, followed by 3 min at 72°C. A 6 μL portion of the
PCR product was separated on 1% agarose gel (GelRed,
Biotium) to check the PCR reactions. Bands were docu-
mented using UV illumination and digital imaging system
(Biorad). PCR products were then purified and amplicons
sequenced with BigDye Chemistry (Applied Biosystems)
before analysis on an ABI PRISM 3100 Genetic Analyzer
(Applied Biosystems).
Results
Faecal egg count reduction test
The FEC from 0-35 d.p.i. revealed patent infection, with
a highest individual egg output of 2350 epg (McMaster)
and a highest total mean (McMaster) of 725 (±246),
1055 (±518) and 435 (±219) epg in groups A, B and
C, respectively, at 32 d.p.i. All animals except two
(100 epg, <50 epg) had a pre-treatment FEC of the rec-
ommended limit 150 epg or above at 35 d.p.i. when ana-
lysed with the McMaster method [17]. FEC revealed a
significant difference (p = 0.03; Log FEC, repeated mea-
sures MANOVA) in egg shedding patterns between iso-
lates A, B and C from 1-45 d.p.i. However, there were
no significant differences (p = 0.34) when comparing the
egg shedding levels of isolates A-C before treatment, i.e.
1-35 d.p.i. (Figure 1). The group-based mean reductions
(arithmetic means) between 35 and 44 d.p.i. were: GroupA: 95% (95% CI 81-99), group B: 98% (92-100) and group
C: 99% (97-100), based on FEC with the McMaster
method. Arithmetic means calculated on individual re-
ductions (Figure 2a) showed similar results in groups A
(96%), B (99%) and C (100%) with the McMaster method
and also in groups A (98%), B (95%) and C (98%) using
FLOTAC data (Figure 2b). Statistical analysis (ANOVA)
showed no significant (p = 0.33) differences between the re-
ductions in the three groups (McMaster) from 35 to 44 d.p.i.
Some animals still excreted eggs (50-150 epg) at 45 d.p.i,
10 days post anthelmintic treatment, in all three groups.
Morphological examination of individual L3 from pooled
cultures indicated that only C. oncophora was present
8-10 days after IVM injection.
Adult worm recoveries
At necropsy 10 days after IVM treatment (45 d.p.i.), ~100
adult O. ostertagi were found in the abomasum of one
single calf in group B, but between 400 and 12, 200
adults of C. oncophora remained in the small intestine of
all treated animals (Table 1). The worm burden of groups
A-C showed no significant differences (p = 0.74), and box
plots (Figure 3) showed larger variation within groups
than between groups.
Larval migration inhibition test
The EC50 values and 95% CI (Table 2) obtained from
L3 representing the three different isolates showed no
significant differences between groups A-C (p = 0.06).
Figure 2 Mean egg output reduction. Mean egg output reduction (95%CI) measured by (a) the McMaster method and (b) the FLOTAC method in
isolates 9 days after treatment (44 d.p.i.) with IVM. Calves in group A were infected with a propagated IVM-susceptible laboratory isolate and those in
groups B and C with two different field isolates showing phenotypic clinical IVM resistance in field trials. Reductions were similar in all three groups.
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three groups, as shown in Figure 4.
Species-specific single larvae PCR (ITS2)
The results from the L3 PCR are shown in Table 3.
Group C was the only group with calves still shedding
O. ostertagi (8%) nematode eggs 7-10 days post IVM
treatment (pooled from faecal samples 42-45 d.p.i.).
Results from cultured faecal samples collected 4 days
before s.c. IVM injections showed about equal proportions
of C. oncophora and O. ostertagi except in group B, where
C. oncophora was the predominant species (82%) pre-
treatment (Table 3).
Discussion
In this study, we performed a controlled efficacy test with
additional available in vivo (e.g. FECRT) and in vitroTable 1 Calf epg data and recovered worms before and
after IVM treatment
Treatment Calf Origin O. ostertagi C. oncophora epg
Males Females Males Females
Before IVM A1 TiHo 2070 3230 6470 5270 750
B1 Sweden 570 670 9070 13600 1000
C1 Sweden 900 2900 1930 3070 400
After IVM A2 TiHo 0 0 3330 5730 150
A3 TiHo 0 0 130 400 <50
B2 Sweden 0 0 6000 6200 50
B3 Sweden 100 0 200 200 <50
C2 Sweden 0 0 600 1600 <50
C3 Sweden 0 0 1000 2000 <50
Calf epg data from day of slaughter, and estimated numbers of adult worms
recovered at necropsy from calves before (31 d.p.i.), and 10 days after (45 d.p.i.)
s.c. injection with ivermectin (Ivomec®, Merial). Calves were previously each
infected with C. oncophora and O. ostertagi, representing isolates with
different deworming history. Calves in group A received equal mixtures of
susceptible laboratory maintained C. oncophora and O. ostertagi from TiHo,
whereas calves in groups B and C received cattle nematodes from two
different farms in Uppland, Sweden, showing phenotypic clinical IVM
resistance in previous field trials.methods (LMIT and species identification of surviving
larvae by PCR), in order to further investigate previously
detected anthelmintic resistance (AR) against Ivomec inj.®
(IVM) in two nematode isolates from two Swedish dairy
farms. This is the first extended investigation of ML resist-
ance in Sweden under experimental conditions, and the
results are somewhat ambiguous.
As in a Belgian survey by El-Abdellati et al. [33], we
failed to confirm suspected AR (<95% FECR), regardless
of the diagnostic sensitivity of the egg counting method
used. Only C. oncophora were found in the coprocultures
morphologically investigated post treatment, whereas PCR
identification of L3 showed that group C calves also shed
O. ostertagi (8%) post treatment. The adult worm recoveries
increased our understanding of the current worm burden,
showing considerable quantities of surviving C. oncophora
but only modest amounts of O. ostertagi. Lifschitz et al.Figure 3 Adult C. oncophora recovered at necropsy post
treatment. Boxplot of estimated numbers of adult C. oncophora
worms recovered at necropsy of calves 10 days after injection (45 d.p.i.)
with IVM. Calves were previously infected with a mixture of
C. oncophora and O. ostertagi, representing isolates with different
deworming histories. Isolate A was propagated IVM-susceptible,
whereas B and C were two different field isolates showing phenotypic
clinical IVM resistance in field trials. Boxplots show larger variation
within groups than between groups.
Table 2 Larval migration inhibition test
IVM A B C
EC50 1.1 μM 1.5 μM 1.5 μM
Conf.-intervals 0.9-1.4 μM 1.3-1.9 μM 1.2-2.1 μM
R2 0.97 0.98 0.95
Results obtained in the LMIT for isolates A, B and C with IVM, including the
EC50 values, estimated 95% confidence intervals and R
2 values.
p = 0.06.
Table 3 Species-specific single larvae PCR (ITS2)
Before IVM 7-10 days post IVM




Results (% O. ostertagi ) from cultured larvae collected separately from groups
A, B and C, 4 days before s.c. IVM injection (31 d.p.i.) and 7-10 days post IVM
treatment (42-45 d.p.i.).
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the intestinal mucosa than in the abomasal mucosa, which
are the predilection sites of C. oncophora and O. ostertagi,
respectively. The pharmacokinetic properties of IVM may
to some extent explain why C. oncophora has a higher
resilience to the drug than O. ostertagi, and why it is the
dose-limiting species. Our results from the LMIT showed
approximately 10-fold higher EC50 values than obtained
previously by Demeler et al. [18,19], but in contrast to
those studies we tested material with mixed species larvae,
which made comparisons difficult.
A deviating finding was that the adult O. ostertagi re-
covered at necropsy came from group B calves, whereas
the larvae from shed eggs post treatment came from
group C calves. In theory, the lack of shed O. ostertagi
eggs in group B could be explained by the fact that the
nematode uterine muscle is one of the most susceptible
target organs for ML [35]. This could mean that the
drug may temporarily suppress nematode egg laying,
even though adult worms survive treatment. Although
we failed to recover adult O. ostertagi from the two
slaughtered calves in group C at necropsy, L3 in faecalFigure 4 Dose-response curves, larval migration inhibition test.
Dose-response curves of the data obtained in LMIT with the three
different isolates of L3 larvae, showing no significant difference
between groups. Calves in group A were infected with equal
mixtures of laboratory-maintained C. oncophora and O. ostertagi
from TiHo, and those in groups B and C with cattle nematodes from
two different farms in Uppland, Sweden, showing phenotypic clinical
IVM resistance in previous field trials.cultures from the same group were observed post treat-
ment according to the species-specific single larva PCR.
The most likely explanation is that these fecund females
were harboured by another calf in group C that was not
slaughtered.
According to the FECRT standard [17,36], all three
isolates investigated in this pen trial were successfully
treated, with reductions ≥95%. However, the criterion for
suspected resistance, i.e. <90 lower limit of the 95% CI,
was fulfilled for isolate A (95%, 81-99), which was included
as the “susceptible” control isolate, when calculated on
group-based means. It was also equal to 90% in isolate A
when means were calculated on individual reductions
using the McMaster method, and in isolate B when
means were calculated on individual reductions using
the FLOTAC method.
The reason for the discrepancy between our results
and those from the previous field trial remains unknown
and needs to be further investigated. In both trials, we
used injectable IVM at the same dose rate. The only
difference was that in the field trial [15], animal weight
was estimated using girth tape, while the animals in the
present pen trial were weighed on scales. The remaining
differentiating factor is that the calves described by
Demeler et al. [15] were dewormed following turn-out.
IVM is a very lipophilic substance with an extensive distri-
bution binding to fatty tissues, including sites of parasite
location [34,37-39]. Its long persistence after subcutaneous
administration to cattle is also based on the deposition of
active drug in fatty tissues [40], which could theoretically
affect pharmacokinetic patterns under field conditions,
since FSG calves in Sweden are well known to suffer
from extensive weight loss during the first month after
the transition to feeding on pasture [41,42]. In contrast,
the animals in this study did not suffer from weight loss
or changes in diet, whereas reduced live weight is fre-
quently observed up to four weeks post turn-out in
Sweden [43].
It has previously also been shown that factors affecting
the pharmacokinetics of IVM clearly affect the efficacy
of the drug [44], but the theory of altered pharmacokin-
etics as a cause of reduced anthelmintic efficacy is still
speculative and few investigations have been carried out.
Accordingly, further trials under field conditions are
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undergo during turnout alter the pharamacokinetics of
the drug, and how this reduces the efficacy of treatment.
Blood samples from field studies where lack of efficacy
in ML treatment has been shown [15] would have been
a helpful tool in distinguishing between the effect of
deviating pharmacokinetics in the host and the effect of
AR in the parasitic nematodes, but unfortunately no
such samples were available.
Conclusions
This study showed that calves experimentally infected
with two different GIN isolates defined as resistant ac-
cording to FECRT were successfully treated, although
considerable numbers of C. oncophora and also small
numbers of O. ostertagi survived IVM treatment. Genetic
AR may be one of several confounding factors leading to
anthelmintic failure, but others, such as differences in the
pharmacokinetic profile in the field versus compared with
in pen trials, cannot yet be excluded.
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